The present invention belongs to the field of pharmaceutical industry and refers to a multilayered coated particle that comprises levodopa, carbidopa in the form of carbidopa monohydrate and carboxylic acid (tartaric acid). The present invention further refers to a pharmaceutical composition and a dosage form comprising one or more of said multilayered coated particle(s). Moreover, the present invention refers to a process for preparing said particle, pharmaceutical composition and dosage form, and to the use of said dosage form in the treatment of Parkinsons disease.
